Pfizer’s (NYSE:PFE) COVID-19 Trial in Children as Young as 12 Years Draws Mixed Sentiments
Pfizer Inc. (NYSE:PFE) recently announced an expansion to its COVID-19 vaccine trial to include teenagers and children of 12 years. The company is the first […]